Antithrombotics for left-ventricular impairment?
Ezekowitz
M
M
Yale Clinical Trials Office, Yale University School of Medicine, New Haven, CT 66510, USA.
D002311:Cardiomyopathy, Dilated / Q000188:drug therapy*; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D018487:Ventricular Dysfunction, Left / Q000188:drug therapy*; D014859:Warfarin / Q000627:therapeutic use*
D005343:Fibrinolytic Agents; D014859:Warfarin